Public Profile

Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC, commonly known as Hikma, is a leading global pharmaceutical company headquartered in the United Kingdom. Founded in 1978, Hikma has established a strong presence in key operational regions, including the Middle East, North Africa, and the United States. The company operates primarily in the generic and branded pharmaceuticals sectors, focusing on injectable medications, oral solids, and complex generics. Hikma is renowned for its commitment to quality and innovation, offering a diverse portfolio of products that cater to various therapeutic areas, including oncology, pain management, and infectious diseases. With a robust market position, Hikma has achieved significant milestones, including numerous FDA approvals and a growing pipeline of new therapies. The company's dedication to improving patient outcomes and expanding access to essential medicines underscores its reputation as a trusted leader in the pharmaceutical industry.

DitchCarbon Score

How does Hikma Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

53

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Hikma Pharmaceuticals's score of 53 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Hikma Pharmaceuticals's reported carbon emissions

In 2023, Hikma Pharmaceuticals reported total carbon emissions of approximately 123,727,000 kg CO2e, comprising 43,830,000 kg CO2e from Scope 1 and 79,897,000 kg CO2e from Scope 2 emissions. The company also disclosed significant Scope 3 emissions, amounting to approximately 836,978,000 kg CO2e, which includes emissions from capital goods, business travel, and purchased goods and services. Hikma has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been detailed in the available data. The company continues to monitor and report its emissions across all relevant scopes, reflecting its engagement with industry standards for climate accountability. Overall, Hikma Pharmaceuticals is actively involved in addressing its carbon emissions, aligning with broader industry efforts to mitigate climate change impacts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20132014201520172018201920202021202220232024
Scope 1
16,817,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
49,779,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Hikma Pharmaceuticals's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Hikma Pharmaceuticals is headquartered in GB, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Hikma Pharmaceuticals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Bausch & Lomb Incorporated

US
Chemicals nec
Updated about 2 months ago
DitchCarbon Score

Endo Inc.

US
Chemicals nec
Updated about 17 hours ago

Phastar

GB
Other services (93)
Updated 23 days ago

Sandoz

CH
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Recipharm

SE
Chemicals nec
Updated about 20 hours ago

Perrigo

IE
Medical, precision and optical instruments, watches and clocks (33)
Updated about 20 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers